Cardiovascular

Efficacy of Huangbai liniment for diabetic foot ulcers with multidrug-resistant organism infection: a randomized controlled multicenter trial.

TL;DR

Topical Huangbai liniment (Tazi therapy) was an effective and safe adjunctive therapy for short-term infection resolution in patients with diabetic foot ulcers and mild MDRO infection, but no evidence emerged for improved ulcer healing within 2 weeks.

Key Findings

Infection resolution was more frequent with Huangbai liniment than with silver dressing in diabetic foot ulcers with mild MDRO infection.

  • Infection was resolved in 35 patients (47.3%) in the HB group versus 13 patients (20.6%) in the SD group (p = 0.001).
  • Analysis included 74 patients in the HB group and 63 in the SD group, out of 154 randomized.
  • Primary outcome was a change from mild infection to no infection, per the IDSA diabetic foot infection guideline.

Mixed-level logistic regression showed HB treatment was associated with higher odds of infection resolution.

  • Odds ratio = 4.81; 95% CI: 2.01-12.48; p < 0.001.

Topical HB facilitated MDRO conversion, a secondary outcome.

  • The abstract states that topical HB 'effectively facilitated mild infection resolution and MDRO conversion'.
  • MDRO conversion rate was a prespecified secondary outcome.

HB did not improve ulcer healing completion or ulcer size reduction within the 2-week treatment period.

  • There was no difference between groups in rate of completing ulcer healing or reduction of ulcer size.
  • Treatment lasted 2 weeks; the authors state longer follow-up is needed to assess wound healing outcomes.

No adverse effects were reported with topical HB.

  • The abstract reports that HB was applied 'with no adverse effects' and concludes it is safe as adjunctive therapy.

The trial was a multicenter, open-label randomized controlled trial in China comparing Tazi therapy with HB to silver dressing, with both groups receiving the same basic diabetic foot treatment.

  • 154 patients with DFUs and mild MDRO infection were randomized; 137 were analyzed (74 HB, 63 SD).
  • The HB group received topical HB (Tazi therapy) for 2 weeks; controls received silver dressing.
  • Registered as ChiCTR2000041443.

What This Means

This study tested whether Huangbai liniment, a standardized herbal product applied to the skin, could help clear infections in diabetic foot ulcers infected with multidrug-resistant bacteria. These infections are hard to treat, raise amputation risk, and long use of broad-spectrum antibiotics can worsen resistance. Researchers at several centers in China compared two weeks of the herbal liniment with silver dressings in 154 patients with mild infections; 137 were analyzed. All patients received the same standard diabetic foot care. Infection cleared in about 47% of patients using the liniment versus about 21% using silver dressings. After statistical adjustment, the liniment group had roughly 4.8 times the odds of infection resolution. The researchers also reported better conversion away from drug-resistant organisms and no adverse effects. However, the liniment did not improve full ulcer healing or shrink ulcers more than silver dressings during the two weeks. The trial was open-label (patients and clinicians knew the treatment) and short. This research suggests the liniment may help with short-term infection control as an add-on treatment, but longer studies are needed to learn whether it improves wound healing.

Have a question about this study?

Citation

Wang N, Wang G, Zhou M, Zhang K, Zhou T, Wang X, et al.. (2026). Efficacy of Huangbai liniment for diabetic foot ulcers with multidrug-resistant organism infection: a randomized controlled multicenter trial.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1926211